
George Lee
609 posts



The Q2 Type B meeting between uniQure and the FDA will be the most important conversation about Huntington's disease in a generation. New CBER leadership. New political pressure from Sen. Johnson's investigation. 48-month data coming this summer. The question isn't whether AMT-130 works. p = .003 answered that. The question is whether the FDA's new leadership is willing to evaluate the data honestly, without the baggage of the last regime. 48,000 families are watching. $QURE #HuntingtonsDisease #AMT130


The Q2 Type B meeting between uniQure and the FDA will be the most important conversation about Huntington's disease in a generation. New CBER leadership. New political pressure from Sen. Johnson's investigation. 48-month data coming this summer. The question isn't whether AMT-130 works. p = .003 answered that. The question is whether the FDA's new leadership is willing to evaluate the data honestly, without the baggage of the last regime. 48,000 families are watching. $QURE #HuntingtonsDisease #AMT130












